OUTCOMES OF ASSISTED REPRODUCTIVE TECHNOLOGY PROGRAMS IN MARRIED COUPLES WITH DIFFERENT TYPES OF PATHOZOOSPERMIA IN MEN


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Background. Increased sperm chromosome aneuploidy may negatively affect the probability of conception in couples with different spermatogenic disorders. Objective. To study the efficiency of assisted reproductive technology (ART) programs in couples with different types of pathozoospermia (PZ) in relation to the rate of sperm chromosome aneuploidy. Subject and methods. The prospective cohort study enrolled 86 married couples treated for infertility in the ART programs, who were divided into three groups: 1) 26 patients with teratozoospermia (TZ); 2) 35 with asthenozoospermia and/or oligizoospermia; 3) 25 with normozoospermia (NZ). The number of sperm chromosomes X, Y, and 18 was estimated by fluorescence in situ hybridization. Ovarian function was stimulated using the uniform short protocol. The primary endpoint was an adjusted odds ratio (OR adj) of conception in relation to the rate of sperm chromosome aneuploidy. The secondary endpoints were the mean rate of sperm chromosome aneuploidy; the mean rate fertilization in the compared patient groups; the threshold level of aneuploidy in the sperm nuclei; a correlation between different spermogram parameters, as well as the rate of fertilization and that of sperm chromosome aneuploidy. Results. Sperm aneuploidy rates statistically significantly differed in the patient groups and were 0.93±0.61% in Group 1, 0.74±0.78% in Group 2, and 0.34±0.12% in Group 3 (p=0.0003). Negative correlations were found between the normal shapes of spermatozoa and the rate of aneuploidy (r=-0.21; p=0.047) and between the rate of sperm aneuploidy and that of fertilization (r=-0.31; p = 0.0035). The ART protocols showed the same number of embryos in the 3 patient groups. Two embryos of equal quality were transferred in each cycle. Twenty-four pregnancies were clinically diagnosed: 4 (15.4%) in Group 1, 8 (22.8%) in Group 2, and 12 (48%) in Group 3 (p=0.0237). OR adj was 4.51 (95% CI=1.09; 18.68). Analysis of the ROC curve of 0.63 determined the threshold value of aneuploidy in the sperm nuclei in relation to the efficiency of ART program, which was 0.7%. Conclusion. Male PZ, TZ in particular, contributes to the increased risk of failures of ART programs. One of these outcomes may be elevated sperm chromosome aneuploidy. Molecular cytogenetic study of ejaculates from men with PZ should be recommended for married couples treated using the in vitro fertilization (IVF)/intracytoplasmic sperm injection technique to make a decision on preimplantation genetic diagnosis of embryos or sperm donation, which may improve the outcomes of IVF programs.

Full Text

Restricted Access

About the authors

V. F DOLGUSHINA

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Email: n_dolgushina@oparina4.ru
Moscow

S. A SOKUR

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Email: sokursv@yandex.ru
Moscow

ZH. I GLINKINA

OOO "Petrovskie Vorota" Maternity and Reproductive Medicine Center

Email: janna435@yandex.ru
Moscow

E. A KALININA

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Email: e_kalinina@oparina4.ru
Moscow

References

  1. World Health Organization. WHO Manual for the standardized investigation and diagnosis of the infertile couple. Cambridge: Cambridge University Press; 2000.
  2. Hofherr S.E., Wiktor A.E., Kipp B.R., Dawson D.B., Van Dyke D.L. Clinical diagnostic testing for the cytogenetic and molecular causes of male infertility: the Mayo Clinic experience. J. Assist. Reprod. Genet. 2011; 28(11): 1091-8.
  3. Bertini V., Simi P., Valetto A. Cytogenetic study of 435 subfertile men: incidence and clinical features. J. Reprod. Med. 2006; 51(1): 15-20.
  4. Tempest H.G., Griffin D.K. The relationship between male infertility and increased levels of sperm disomy. Cytogenet. Genome Res. 2004; 107(1-2): 83-94.
  5. Mehdi M., Gmidene A., Brahem S., Guerin J., Elghezal H., Saad A. Aneuploidy rate in spermatozoa of selected men with severe teratozoospermia. Andrologia. 2012; 44(Suppl. 1): 139-43.
  6. Долгушина Н.В., Ратушняк С.С., Сокур С.А., Глинкина Ж.И., Калинина Е.А. Риск анеуплоидии эмбрионов в программах вспомогательных репродуктивных технологий у мужчин с патозооспермией (мета-анализ). Акушерство и гинекология. 2012; 7: 4-13.
  7. Coetzee K., Kruge T.F., Lombard C.J. Predictive value of normal sperm morphology: a structured literature review. Hum. Reprod. Update. 1998; 4(1): 73-82.
  8. Van Waart J., Kruger T.F., Lombard C.J., Ombelet W. Predictive value of normal sperm morphology in intrauterine insemination (IUI): a structured literature review. Hum. Reprod. Update. 2001; 7(5): 495-500.
  9. Nicopoullos J.D., Gilling-Smith C., Almeida P.A., Homa S.,Nice L., Tempest H., Ramsay J. W. The role of sperm aneuploidy as a predictor of the success of intracytoplasmic sperm injection? Hum. Reprod. 2008; 23(2): 240-50.
  10. RubioC., Gil-Salom M., Simon C., Vidal F., Rodrigo L., Minguez Y. et al. Incidence of sperm chromosomal abnormalities in a risk population: relationship with sperm quality and ICSI outcome. Hum. Reprod. 2001; 16(10): 2084-92.
  11. Blanco J., Gabau E., Gomez D., Baena N., Guitart M., Egozcue J., Vidal F. Chromosome 21 disomy in the spermatozoa of the fathers of children with trisomy 21, in a population with high prevalence of Down syndrome increased incidence in cases of paternal origin. Am. J. Hum. Genet. 1998; 63(4): 1067-72.
  12. Brahem S., Mehdi M., Elghezal H., Saad A. Detection of DNA fragmentation and meiotic segregation in human with isolated teratozoospermia. J. Assist. Reprod. Genet. 2011; 28(1): 41-8.
  13. Mehdi M., Smatti B., Saad A., Guerin J.F., Benchaib M. Analysis by fluorescence in situ hybridization (FISH) of the relationship between gonosomic aneuploidy and the results of assisted reproduction in men with severe oligozoospermia. Andrologia. 2006; 38(4): 137-41.
  14. Collodel G., Capitani S., Baccetti B., Pammolli A., Moretti E. Sperm aneuploidies and low progressive motility. Hum. Reprod. 2007; 22(7): 1893-8.
  15. Cooper T.G., Noon an E., von Eckardstein S., Auger J., Baker H. W., Behre H.M. et al. World Health Organization reference values for human semen characteristics. Hum. Reprod. Update. 2010; 16(3): 231-45.
  16. Приказ Минздрава России от 30.08.2012 N 107н “О порядке использования вспомогательных репродуктивных технологий, противопоказаниях и ограничениях к их применению”. http: //www.rosminzdrav.ru/docs/ mzsr/orders/1363
  17. Guttenbach M., Schakowski R., Schmid M. Incidence of chromosome 3, 7, 10, 11, 17 and X disomy in mature human sperm nuclei as determinant by nonradioactive in situ hybridization. Hum. Genet. 1994; 93(1): 7-12.
  18. FISH chromosome search technology by Abbott Molecular. http: //www.abbottmolecular.com/us/technologies/fish/ vysis-chromosome-search.html
  19. Akl L.D., Oliveira J.B., Petersen C.G., Mauri A.L., Silva L.F., Massaro F.C. et al. Efficacy of the motile sperm organelle morphology examination (MSOME) in predicting pregnancy after intrauterine insemination. Reprod. Biol. Endocrinol. 2011; 9: 120.
  20. Younes B.G., Hazzouri K.M., Chaaban M.J., Karam W.G., Abou Jaoude I.F., Attieh J.H., Hazzouri M.M. High frequency of sex chromosomal disomy in spermatozoa of Lebanese infertile men. J. Androl. 2011; 32(5): 518-23.
  21. Calogero A.E., De Palma A., Grazioso C., Barone N., Romeo R., Rappazzo G., D’Agata R. Aneuploidy rate in spermatozoa of selected men with abnormal semen parameters. Hum. Reprod. 2001; 16(6): 1172-9.
  22. Tang S.S., Gao H., Zhao Y., Ma S. Aneuploidy and DNA fragmentation in morphologically abnormal sperm. Int. J. Androl. 2010; 33(1): e163-79.
  23. Lu Y.H., Gao H.J., Li B.J., Zheng Y.M., Ye Y.H., Qian Y.L. et al. Different sperm sources and parameters can influence intracytoplasmic sperm injection outcomes before embryo implantation. J. Zhejiang Univ. Sci. B. 2012; 13(1): 1-10.

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies